Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **tear film and ocular surface** are a tightly integrated anatomical and functional unit critical for vision, comfort, and protection of the eye. The tear film is comprised of three layers—lipid (outer), aqueous (middle), and mucin (inner)—spanning the corneal and conjunctival epithelium, and maintained through secretions of the lacrimal and meibomian glands. This multilayered structure provides lubrication, stability for optical refraction, defense against pathogens, and nourishment to ocular tissues. Dysfunction of any component can lead to **dry eye disease**, impaired vision, increased infection risk, and ocular discomfort. Therapeutic approaches focus on supplementing or restoring tear film integrity and treating underlying glandular or surface pathology, rather than targeting a specific molecule or receptor[1][3][5].
Drug supplementation of tear constituents (lubrication, hydration)[1][5] Anti-inflammatory modalities suppressing ocular surface immune activation[1] Stimulation of normal tear secretion and Meibomian gland function[1][5] Direct antimicrobial action (for infection)[5]
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tear film and ocular surface.